Cargando…
Succinylation and redox status in cancer cells
Succinylation is a post-translational modification (PTM) event that associates metabolic reprogramming with various pathological disorders including cancers via transferring a succinyl group to a residue of the target protein in an enzymic or non-enzymic manner. With our incremental knowledge on the...
Autores principales: | Dai, Xiaofeng, Zhou, Yanyan, Han, Fei, Li, Jitian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807787/ https://www.ncbi.nlm.nih.gov/pubmed/36605449 http://dx.doi.org/10.3389/fonc.2022.1081712 |
Ejemplares similares
-
The involvement of high succinylation modification in the development of prostate cancer
por: Zhang, Zhenyang, et al.
Publicado: (2022) -
When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies
por: Dai, Xiaofeng, et al.
Publicado: (2022) -
A review of the mechanism of succinylation in cancer
por: Lu, Keer, et al.
Publicado: (2022) -
Histone succinylation and its function on the nucleosome
por: Liu, Jiayi, et al.
Publicado: (2021) -
Nanogels of Succinylated Glycol Chitosan-Succinyl Prednisolone Conjugate: Preparation, In Vitro Characteristics and Therapeutic Potential
por: Zhou, Haiyan, et al.
Publicado: (2019)